Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010

Alkermesa? Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. -at-the-credit-suisse-healthcare-conference.html
Published in Health and Fitness on Friday, November 5th 2010 at 6:07 GMT by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Credit Suisse Healthcare Conference on Thursday, November 11, 2010, at 11:00 a.m. MT (1:00 p.m. ET) from the Arizona Biltmore in Phoenix, Arizona. The presentation may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.


Publication Contributing Sources